Charles River Discovery Services is licensed to carry out biodistribution studies with C14- and H3-labeled molecules. Biodistribution studies with C- and H-labeled molecules help determine the targeting and tumor specificity of a test agent. On-site determination of radiolabeled levels in samples is possible.
We also have the capability of administering radiation as a therapy using a Faxitron Model CP-160 instrument. This capability enables the use of radiation for:
- Combination radiation/chemotherapy
- In vitro applications
For more information about our radiation services, please contact us at 1.877.CRIVER.1 or email@example.com.